Skip to main content
TipRanks
Go Ultimate75% OFF

Science Applications (SAIC) AI Stock Analysis

749 Followers
SAIC

Science Applications

(NASDAQ:SAIC)

Select Model
Rating:71Outperform
Price Target:$162.00â–²(11.93% Upside)
Action:reiterated
Date:10/13/26

SAIC scores solidly on strong free-cash-flow generation and a technically healthy uptrend (price above key moving averages with supportive momentum). The score is tempered by moderate profitability with margin compression versus 2024 and mixed balance-sheet signals around leverage/equity trends, while valuation is reasonable and recent corporate actions are generally positive but not transformational.

Positive Factors
Strong cash generationRobust operating and free cash flow supports earnings quality and gives SAIC internally generated funds for investment, debt service, dividends, and contract execution. FCF tracking net income closely suggests reported profitability is translating into usable cash.
Negative Factors
Margin compressionLower margins indicate reduced operating leverage or higher costs compared with 2024, limiting how much revenue growth converts into earnings. If this persists, SAIC may have less flexibility to invest in capabilities, absorb contract pressure, or expand shareholder returns.

Science Applications Key Performance Indicators (KPIs)

Total BacklogIndicates the total value of contracted work yet to be completed, highlighting future revenue streams and the company's ability to secure long-term projects.

$0.00$5.00B$10.00B$15.00B$20.00B$25.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Backlog has traded in a roughly $22–24B band since 2021, dipping in 2024 then recovering through 2025—suggesting steady contract visibility rather than a breakout. That pickup aligns with Q1 book‑to‑bill >1 and a large $85B qualified pipeline, which helps explain the margin and cash improvements; however, management’s warning about the RITS recompete, a trimmed enterprise‑IT funnel and slower RFP timing means backlog may sustain revenue visibility but won't guarantee stronger organic growth without improved bookings and recompete wins.

Data provided by:The Fly

Science Applications (SAIC) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%100%SAIC+72.53%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$6.06B
Dividend Yield
1.02%
Average Volume (3M)
456.22K
Price to Earnings (P/E)
16.7
Beta (1Y)
0.35
Revenue Growth
-0.78%
EPS Growth
3.90%
Country
US
Employees
23,000
Sector
Technology
Sector Strength
61
Industry
Information Technology Services

Science Applications Business Overview & Revenue Model

Company Description

Science Applications International Corporation (SAIC), a U.S.-based firm, specializes in providing a wide array of advanced technical, engineering, and comprehensive information technology (IT) solutions. Its diverse offerings span crucial areas such...

How the Company Makes Money

SAIC primarily makes money by performing services and delivering technology solutions under contracts with U.S. government agencies. Revenue is recognized as contract work is performed and deliverables/services are provided, and the company’s earning...

Science Applications Earnings Call Summary

Earnings Call Date:Jun 01, 2026(Q1-2027)|% Change Since:39.75%|Next Earnings Date:Dec 03, 2026
Earnings Call SentimentPositive

The call emphasized strong operational execution in Q1 — record margins, robust adjusted EBITDA ($222M), improved civil margins (~15%), upgraded EPS and EBITDA guidance, solid free cash flow generation and active capital return via buybacks. Management remains cautious on sales for FY27 due to recompete timing (notably RITS), a smaller/reshaped enterprise IT pipeline, slower RFP timing and election-year/appropriations uncertainty. While some margin upside in the quarter was aided by a one-time venture gain, underlying cash flow and deleveraging progress are clear. Overall, the company appears to be making deliberate strategic changes (portfolio and pipeline focus) and has momentum on margins and cash, but faces identifiable timing and organic growth risks that management is actively managing.

Positive Updates

Record Margin and Strong Adjusted EBITDA
Fiscal Q1 adjusted EBITDA of $222 million and a company-record margin driven by strong program execution; sale of a venture investment contributed roughly $12 million, adding ~60 basis points to EBITDA margin and about $0.20 to EPS.

Negative Updates

RITS Recompete Headwind and Timing Shift
Unsuccessful RITS recompete expected to be a ~$200 million headwind in FY27; roll-off timing shifted later (now likely to impact Q3 rather than Q2) due to a protest, creating sequential timing pressure in the second half of the year.

Company Guidance

SAIC maintained its FY2027 sales guidance but raised profitability and EPS outlook after a strong F1Q: Q1 revenue $1.9B (+0.5% organic), adjusted EBITDA $222M (included $12M venture IPO gain that added ~60bps to EBITDA margin and ~$0.20 to EPS), adjusted diluted EPS $3.23, free cash flow $118M, net leverage down to 3.1x, net bookings $2.1B (book‑to‑bill 1.1x; 1.0x TTM) and a qualified pipeline of ~$85B. Management raised full‑year adjusted EBITDA margin guidance to 10.1%–10.3% (up ~20bps), increased adjusted EPS guidance ~4% to $9.90–$10.10, reiterated FCF >$600M and at least $14 FCF/share in FY27 (and ≥$13 in FY28), expects on‑contract growth of 2%–3%, will revisit organic growth (previous guide −2% to −4%) at Q2, repurchased $188M this quarter toward a ~ $400M buyback plan, and said the ~$200M RITS recompete headwind will likely roll off in Q3 (implying roughly a ~3% organic drag in each of Q3 and Q4).

Science Applications Financial Statement Overview

Summary

Cash flow is the standout (TTM FCF $619M with strong growth and ~0.94x conversion vs net income), supporting earnings quality. However, profitability is only moderate (TTM net margin ~5.1%, EBIT margin ~8.0%) and margins have compressed versus 2024 levels, while balance-sheet trends show caution flags (historically higher debt-to-equity and declining equity in annual figures despite strong ROE).

Income Statement

67Positive

Balance Sheet

60Neutral

Cash Flow

74Positive
Financial statement breakdown
BreakdownTTMJan 2026Jan 2025Jan 2024Jan 2023Jan 2022
Income Statement
Total Revenue7.40B7.26B7.48B7.44B7.70B7.39B
Gross Profit936.00M879.00M892.00M872.00M888.00M859.00M
EBITDA749.00M661.00M686.00M882.00M650.00M628.00M
Net Income380.00M358.00M362.00M477.00M300.00M277.00M
Balance Sheet
Total Assets5.42B5.35B5.25B5.31B5.54B5.75B
Cash, Cash Equivalents and Short-Term Investments126.00M182.00M56.00M94.00M109.00M106.00M
Total Debt2.71B2.71B2.39B2.25B2.53B2.71B
Total Liabilities3.99B3.85B3.67B3.53B3.84B4.12B
Stockholders Equity1.44B1.50B1.58B1.78B1.69B1.62B
Cash Flow
Free Cash Flow619.00M577.00M458.00M369.00M507.00M482.00M
Operating Cash Flow660.00M609.00M494.00M396.00M532.00M518.00M
Investing Cash Flow-240.00M-248.00M-35.00M314.00M-36.00M-292.00M
Financing Cash Flow-342.00M-235.00M-498.00M-725.00M-493.00M-301.00M

Science Applications Technical Analysis

Technical Analysis SentimentNeutral
Last Price144.73

Price Trends

50DMA137.70Positive
100DMA128.87Positive
200DMA112.89Positive

Market Momentum

MACD3.37Positive
RSI49.92Neutral
STOCH45.91Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SAIC, the sentiment is Neutral. The current price of 144.73 is below the 20-day moving average (MA) of 148.65, above the 50-day MA of 137.70, and above the 200-day MA of 112.89, indicating a neutral trend. The MACD of 3.37 indicates Positive momentum. The RSI at 49.92 is Neutral, neither overbought nor oversold. The STOCH value of 45.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SAIC.

Science Applications Risk Analysis

Science Applications disclosed 29 risk factors in its most recent earnings report. Science Applications reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

2 New Risks
1.The U.S. government may issue or revise existing rules, regulations, and directives at any time, creating uncertainty and requiring unanticipated investments in related compliance efforts.Q4, 2024
2.We use and deploy AI solutions for our customers which may result in harm to our reputation or liability if they do not function as predicted.Q1, 2024

Science Applications Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SAIC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ACNACN84Outperform$141.42B17.6326.77%2.76%6.47%11.19%
IBMIBM79Outperform$218.41B19.4532.95%2.92%6.83%39.80%
LDOSLDOS73Outperform$15.65B11.3928.04%1.34%2.67%4.32%
CACICACI72Outperform$13.86B25.5112.37%―10.12%7.58%
SAICSAIC71Outperform$6.06B16.7225.89%1.02%-0.78%3.90%
PSNPSN67Neutral$5.34B36.585.58%―-2.67%-61.86%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%

* Technology Sector Average

Performance Comparison

-50%0%50%SAICACNCACIIBMLDOSPSNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SAIC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SAICScience Applications International Corp.144.7360.1071.02%
ACNAccenture Plc239.286.312.71%
CACICaci International624.0121.163.51%
IBMInternational Business Machines Corporation231.09-49.74-17.71%
LDOSLeidos Holdings Inc128.25-58.76-31.42%
PSNParsons Corp50.64-32.65-39.20%

Science Applications Corporate Events

Private Placements and Financing

Science Applications Completes $500 Million Senior Notes Offering

Neutral
Nov 13, 2026

On November 13, 2026, Science Applications International Corporation closed a private offering of $500 million aggregate principal amount of 6.750% senior notes due 2034, receiving approximately $493 million in net proceeds after discounts and estima...

Private Placements and Financing

SAIC Prices $500 Million Senior Notes Offering

Neutral
Nov 2, 2026

On November 2, 2026, SAIC announced it had commenced and priced a private offering of $500 million in senior notes due 2034. The announced use of proceeds was to redeem all outstanding 4.875% senior notes due 2028 and cover offering costs, with remai...

Business Operations and StrategyExecutive/Board Changes

Science Applications announces key executive leadership appointments

Positive
Oct 13, 2026

On Oct. 13, 2026, SAIC announced two senior leadership changes designed to bolster its executive bench and support long-term growth. Prabu Natarajan, previously serving as interim head, was appointed permanent Executive Vice President of the Civilian...

Business Operations and StrategyDividends

Science Applications Declares Quarterly Cash Dividend, Signals Confidence

Positive
Aug 28, 2026

On August 27, 2026, Science Applications International Corp.’s board of directors declared a cash dividend of $0.37 per share on its common stock, payable on October 23, 2026 to shareholders of record as of October 9, 2026. The decision reinforces SA...

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance

Science Applications Expands Government Receivables Financing Capacity

Positive
Aug 19, 2026

On August 14, 2026, Science Applications International Corporation amended its Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd., raising the facility limit for certain eligible U.S. government receivables from $300 million to $400 m...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 13, 2026